Requirement for epithelial p38α in KRAS-driven lung tumor progression
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Requirement for epithelial p38α in KRAS-driven lung tumor progression
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 117, Issue 5, Pages 2588-2596
Publisher
Proceedings of the National Academy of Sciences
Online
2020-01-23
DOI
10.1073/pnas.1921404117
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- c-RAF Ablation Induces Regression of Advanced Kras/Trp 53 Mutant Lung Adenocarcinomas by a Mechanism Independent of MAPK Signaling
- (2018) Manuel Sanclemente et al. CANCER CELL
- Myeloid p38α signaling promotes intestinal IGF‐1 production and inflammation‐associated tumorigenesis
- (2018) Catrin Youssif et al. EMBO Molecular Medicine
- Recognizing the Molecular Multifunctionality and Interactome of TIMP-1
- (2018) Barbara Grünwald et al. TRENDS IN CELL BIOLOGY
- Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA
- (2017) Matthew A. Coelho et al. IMMUNITY
- Tissue inhibitor of metalloproteinase-1 promotes cell proliferation through YAP/TAZ activation in cancer
- (2017) T Ando et al. ONCOGENE
- Proline isomerisation as a novel regulatory mechanism for p38MAPK activation and functions
- (2016) A Brichkina et al. CELL DEATH AND DIFFERENTIATION
- Drugging the addict: non‐oncogene addiction as a target for cancer therapy
- (2016) Remco Nagel et al. EMBO REPORTS
- p38MAPK builds a hyaluronan cancer niche to drive lung tumorigenesis
- (2016) Anna Brichkina et al. GENES & DEVELOPMENT
- The Stress Kinase p38 as a Target for Cancer Therapy
- (2015) A. Igea et al. CANCER RESEARCH
- The 2015 World Health Organization Classification of Lung Tumors
- (2015) William D. Travis et al. Journal of Thoracic Oncology
- Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression
- (2015) Muhammad S Alam et al. NATURE MEDICINE
- Dual Function of p38α MAPK in Colon Cancer: Suppression of Colitis-Associated Tumor Initiation but Requirement for Cancer Cell Survival
- (2014) Jalaj Gupta et al. CANCER CELL
- Modeling Lung Cancer Evolution and Preclinical Response by Orthotopic Mouse Allografts
- (2014) C. Ambrogio et al. CANCER RESEARCH
- p38 MAPK in Pancreatic Cancer: Finding a Protective Needle in the Haystack
- (2014) M. Korc CLINICAL CANCER RESEARCH
- Multiple cells-of-origin of mutant K-Ras–induced mouse lung adenocarcinoma
- (2014) Kate D. Sutherland et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phosphorylated p38, a negative prognostic biomarker, complements TNM staging prognostication in colorectal cancer
- (2014) Xin-Juan Fan et al. TUMOR BIOLOGY
- A paracrine network regulates the cross-talk between human lung stem cells and the stroma
- (2014) E. Josue Ruiz et al. Nature Communications
- Sunlight UV-Induced Skin Cancer Relies upon Activation of the p38 Signaling Pathway
- (2013) K. Liu et al. CANCER RESEARCH
- A Posttranslational Modification Cascade Involving p38, Tip60, and PRAK Mediates Oncogene-Induced Senescence
- (2013) Hui Zheng et al. MOLECULAR CELL
- A role for p38 MAPK in head and neck cancer cell growth and tumor-induced angiogenesis and lymphangiogenesis
- (2013) Kantima Leelahavanichkul et al. Molecular Oncology
- Dual specificity phosphatase 1 expression inversely correlates with NF-κB activity and expression in prostate cancer and promotes apoptosis through a p38 MAPK dependent mechanism
- (2013) Beatriz Gil-Araujo et al. Molecular Oncology
- Identification of cancer initiating cells in K-Ras driven lung adenocarcinoma
- (2013) S. Mainardi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy and safety of the oral p38 inhibitor PH-797804 in chronic obstructive pulmonary disease: a randomised clinical trial
- (2013) William MacNee et al. THORAX
- A Reversible Gene-Targeting Strategy Identifies Synthetic Lethal Interactions between MK2 and p53 in the DNA Damage Response In Vivo
- (2013) Sandra Morandell et al. Cell Reports
- The GATA2 Transcriptional Network Is Requisite for RAS Oncogene-Driven Non-Small Cell Lung Cancer
- (2012) Madhu S. Kumar et al. CELL
- Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model
- (2012) Yifeng Xia et al. NATURE CELL BIOLOGY
- Evidence for type II cells as cells of origin of K-Ras-induced distal lung adenocarcinoma
- (2012) X. Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- c-Raf, but Not B-Raf, Is Essential for Development of K-Ras Oncogene-Driven Non-Small Cell Lung Carcinoma
- (2011) Rafael B. Blasco et al. CANCER CELL
- p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype
- (2011) Adam Freund et al. EMBO JOURNAL
- Mechanisms and functions of p38 MAPK signalling
- (2010) Ana Cuadrado et al. BIOCHEMICAL JOURNAL
- Mitogen-Activated Protein Kinase Activation in Lung Adenocarcinoma: A Comparative Study between Ever Smokers and Never Smokers
- (2008) G. Mountzios et al. CLINICAL CANCER RESEARCH
- p38α MAPK inhibits JNK activation and collaborates with IκB kinase 2 to prevent endotoxin-induced liver failure
- (2008) Jan Heinrichsdorff et al. EMBO REPORTS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started